Registry Trial to Evaluate the Clinical Utilization of Targeted Axillary Dissection (TAD)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Early Stage Breast Cancer
Interventions: OTHER: Not suitable for TAD|PROCEDURE: Suitable for TAD
Sponsor: Kliniken Essen-Mitte
Collaborators: German Breast Group